000
| 01997nam 2200385zi 4500 |
---|
001 | 9.907333 |
---|
003 | CaOODSP |
---|
005 | 20221107181348 |
---|
006 | m o d f |
---|
007 | cr cn||||||||| |
---|
008 | 220126e202202##oncd obs f000 0 eng d |
---|
020 | |a9780660417950 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH82-29/3-2022E-PDF |
---|
245 | 00|aAlignment among public formularies in Canada, part 3 : |bmedicines assessed by the common drug review. |
---|
264 | 1|aOttawa, ON : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |cFebruary 2022. |
---|
264 | 4|c©2022 |
---|
300 | |a1 online resource (iii, 21 pages) : |bcolour charts |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Concordance des listes de médicaments des régimes publics au Canada, partie 3 : médicaments évalués par le programme commun d'évaluation des médicaments. |
---|
500 | |aIssued also in HTML format. |
---|
504 | |aIncludes bibliographical references. |
---|
520 | |a"This is the last report in a three-part PMPRB series that explores current overlaps and gaps in Canadian public drug plan formularies"--Executive summary, page ii. |
---|
650 | 0|aPharmaceutical services insurance|zCanada|vStatistics. |
---|
650 | 0|aDrugs|zCanada|vStatistics. |
---|
650 | 0|aPharmaceutical policy|zCanada. |
---|
655 | 7|aStatistics|2lcgft |
---|
710 | 1 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body. |
---|
775 | 08|tConcordance des listes de médicaments des régimes publics au Canada, partie 3 : |w(CaOODSP)9.907335 |
---|
856 | 40|qPDF|s2.60 MB|uhttps://publications.gc.ca/collections/collection_2022/cepmb-pmprb/H82-29-3-2022-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/formularies-part3-medicines-assessed.html |
---|